Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability of Fesoterodine and Oxytbutynin XL
and to compare their efficacy for overactive bladder syndrome in children.